3-cyano-7-ethoxycoumarin has been researched along with ethoxyresorufin in 1 studies
| Studies (3-cyano-7-ethoxycoumarin) | Trials (3-cyano-7-ethoxycoumarin) | Recent Studies (post-2010) (3-cyano-7-ethoxycoumarin) | Studies (ethoxyresorufin) | Trials (ethoxyresorufin) | Recent Studies (post-2010) (ethoxyresorufin) |
|---|---|---|---|---|---|
| 6 | 0 | 3 | 241 | 1 | 39 |
| Protein | Taxonomy | 3-cyano-7-ethoxycoumarin (IC50) | ethoxyresorufin (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chibale, K; Dhansay, K; Masimirembwa, CM; Smith, P; Thelingwani, RS | 1 |
1 other study(ies) available for 3-cyano-7-ethoxycoumarin and ethoxyresorufin
| Article | Year |
|---|---|
Potent inhibition of CYP1A2 by Frutinone A, an active ingredient of the broad spectrum antimicrobial herbal extract from P. fruticosa.
Topics: Anti-Infective Agents; Catalytic Domain; Chromones; Coumarins; Cryopreservation; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Drug Evaluation, Preclinical; Enzyme Inhibitors; Hepatocytes; Humans; Isoenzymes; Kinetics; Mass Spectrometry; Metabolic Networks and Pathways; Molecular Docking Simulation; Nitriles; Oxazines; Plant Extracts; Polygala; Reproducibility of Results; Substrate Specificity; Time Factors | 2012 |